Opioid-induced neurotoxicity after opioid conversion to methadone in patients with cancer pain using the stop-and-go method: A multicenter retrospective cohort study
Por:
Calsina-Berna, A, González-Barboteo, J, Esteve, A, Torromé, SL, Juarros, GS, Pérez, MB, Miranda, IC, Pardo, MA, Mendoza, LN, Ballart, PG, Cuadros-Margarit, R, Plaza, MO, Sequeiros, CAC, Trias, ML, Cuenca-Casbas, P, Bavestrello, P, Rodrigo, MA, Roda, IB and Julià-Torras, J
Publicada:
11 ene 2026
Resumen:
Purpose To describe the frequency of opioid-induced neurotoxicity (OINT) after opioid conversion (OC) to methadone using the Stop-and-Go (SAG) method in cancer patients with inadequate pain control, and to identify factors associated with OINT. Methods This multicenter retrospective cohort study included adult hospitalized cancer patients who underwent OC to methadone using the SAG method for poor pain control at two comprehensive cancer centers between January 2018 and October 2022. Patients were monitored 14 days after OC, and variables related to OINT were analyzed. Ethical approval was obtained. Results A total of 372 patients underwent OC using the SAG method. The mean morphine-equivalent daily dose (MEDD) before OC was 212.2 mg (SD 128). OINT occurred in 70 patients (18.8%). Methadone was permanently discontinued in 2 patients (2.8%) and temporarily withheld in 7, while 61 were managed with hydration and a 15-20% methadone dose reduction. No patient required naloxone. OINT was less frequent in younger patients (mean age 59.4 vs. 63 years; p = 0.032) and showed a trend toward lower incidence in women (13% vs.22%; p = 0.065). Preexisting cognitive impairment or delirium was associated with OINT (52.4% vs.16.8%; p < 0.001). The mean time from OC to death was shorter among patients with OINT (2.1 months; SD 3.9) compared with those without OINT (3.6 months; SD 6.4; p = 0.012). Conclusion OC to methadone using the SAG method in patients with low-to-moderate MEDD was associated with a relatively low OINT frequency (18.8%). These findings suggest that SAG method in patients with low-to-moderate MEDD before OC may be safe, particularly for younger patients and those without cognitive impairment.
Filiaciones:
Calsina-Berna, A:
Inst Catala Oncol Badalona, Catalan Inst Oncol GRICOPAL, Res & Knowledge Grp Palliat Care, Palliat Care Dept, Badalona, Spain
Univ Vic Cent Univ Catalonia UVic UCC, Fac Med, Manresa, Catalonia, Spain
González-Barboteo, J:
Univ Vic Cent Univ Catalonia UVic UCC, Fac Med, Manresa, Catalonia, Spain
:
Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol ICO, Med Oncol Serv,IGTP, Badalona Appl Res Grp Oncol,B ARGO CARE Program, Badalona, Spain
Torromé, SL:
Inst Catala Oncol Hosp, Res & Knowledge Grp Palliat Care Catalan Inst Onco, Palliat Care Dept, Barcelona, Spain
Juarros, GS:
Inst Catala Oncol Hosp, Res & Knowledge Grp Palliat Care Catalan Inst Onco, Palliat Care Dept, Barcelona, Spain
Pérez, MB:
Inst Catala Oncol Badalona, Palliat Care Dept, Badalona, Spain
Miranda, IC:
Consorci Sanit Terrassa, Anesthesiol Dept, Terrassa, Spain
Pardo, MA:
Inst Catala Oncol Badalona, Palliat Care Dept, Badalona, Spain
Mendoza, LN:
Inst Catala Oncol Badalona, Palliat Care Dept, Badalona, Spain
Ballart, PG:
Inst Catala Oncol Badalona, Palliat Care Dept, Badalona, Spain
Cuadros-Margarit, R:
Inst Catala Oncol Hosp, Res & Knowledge Grp Palliat Care Catalan Inst Onco, Palliat Care Dept, Barcelona, Spain
Plaza, MO:
Inst Catala Oncol Hosp, Res & Knowledge Grp Palliat Care Catalan Inst Onco, Palliat Care Dept, Barcelona, Spain
Sequeiros, CAC:
Inst Catala Oncol Hosp, Res & Knowledge Grp Palliat Care Catalan Inst Onco, Palliat Care Dept, Barcelona, Spain
Trias, ML:
Inst Catala Oncol Hosp, Res & Knowledge Grp Palliat Care Catalan Inst Onco, Palliat Care Dept, Barcelona, Spain
Cuenca-Casbas, P:
Inst Catala Oncol Badalona, Palliat Care Dept, Badalona, Spain
Bavestrello, P:
Inst Catala Oncol Hosp, Res & Knowledge Grp Palliat Care Catalan Inst Onco, Palliat Care Dept, Barcelona, Spain
Rodrigo, MA:
Inst Catala Oncol Badalona, Pharm Unit, Badalona, Spain
Roda, IB:
Inst Catala Oncol Badalona, Palliat Care Dept, Badalona, Spain
Julià-Torras, J:
Univ Int Catalunya, Sch Med & Hlth Sci, Barcelona, Spain
Inst Catala Oncol Badalona, Palliat Care Dept, Badalona, Spain
|